|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5797 USD | +1.01% |
|
+2.31% | -0.07% |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Dec. 17 | VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 19.3M | - | - | - | - | ||||
| 49.82B | AA | |||||||
| 42.19B | AAA | |||||||
| 33.34B | - | BBB | - | - | ||||
| 29.61B | - | - | - | - | ||||
| 20.36B | AAA | |||||||
| 20.15B | AA | |||||||
| 13.47B | B | - | ||||||
| 12.84B | - | A | - | - | ||||
| 12.99B | - | - | - | - | ||||
| 11.99B | - | - | - | - | - | - | - | |
| 12.06B | BB | |||||||
| 11.29B | - | B | - | - | ||||
| 10.93B | - | - | - | - | - | - | - | |
| 10.45B | - | - | - | - | - | - | - | |
| 9.29B | - | BBB | - | - | ||||
| 8.47B | - | CCC | - | - | ||||
| 8.19B | - | - | - | - | - | - | - | |
| 7.71B | - | AA | - | - | ||||
| 7.7B | - | - | ||||||
| Average | 16.64B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Equities
- VYNE Stock
- Sector VYNE Therapeutics Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
